Runx-IN-1 features a peptide-like scaffold designed to probe transcription factor interactions and sequence-specific binding. Its functional groups support studies of hydrogen bonding, aromatic stacking, and steric complementarity. Researchers examine its conformational behavior across varied solvent environments. Applications include structural biology, ligand screening, and protein-peptide interaction mapping.
CAT No: R2627
CAS No:2177285-35-5
Synonyms/Alias:RUNX-IN-1;2177285-35-5;CHEMBL5439890;SCHEMBL21265820;EX-A9848;DA-77588;HY-155990;CS-0890924;
Runx-IN-1 is a specialized small molecule inhibitor designed to modulate the activity of the Runt-related transcription factor (RUNX) family, which plays a pivotal role in the regulation of gene expression involved in cellular differentiation, proliferation, and lineage specification. As a targeted research tool, Runx-IN-1 enables scientists to investigate the intricate signaling pathways governed by RUNX proteins, offering a precise approach to dissecting the molecular mechanisms underlying various biological processes. Its selective mode of action makes it an invaluable asset for in vitro studies seeking to unravel the functional dynamics of transcription factors in complex cellular environments. Researchers benefit from its capacity to provide reproducible and consistent results, facilitating advanced exploration in both basic and translational research settings.
Cancer Biology Research: In oncology laboratories, Runx-IN-1 is frequently employed to probe the role of RUNX transcription factors in tumorigenesis and cancer progression. By selectively inhibiting RUNX activity, investigators can delineate the contributions of these proteins to cell cycle regulation, apoptosis, and metastatic potential. The inhibitor serves as a critical tool for mapping oncogenic signaling cascades and identifying novel molecular targets for cancer therapy. Through its application, researchers gain insights into the interplay between transcriptional regulation and tumor cell behavior, supporting the development of innovative strategies for cancer intervention.
Stem Cell Differentiation Studies: The use of Runx-IN-1 extends to stem cell biology, where it aids in elucidating the influence of RUNX factors on lineage commitment and differentiation. By modulating the transcriptional landscape, the compound allows scientists to examine how RUNX proteins orchestrate the transition from pluripotent stem cells to specialized cell types. This approach is instrumental for uncovering the regulatory hierarchies that govern cell fate decisions, enabling the optimization of protocols for directed differentiation and tissue engineering applications.
Developmental Biology Investigations: In developmental biology, the application of this inhibitor facilitates the study of gene regulatory networks that drive embryonic development and organogenesis. Researchers utilize Runx-IN-1 to transiently suppress RUNX-dependent transcription, thereby uncovering the temporal and spatial roles of these factors during critical stages of development. This targeted intervention helps clarify the molecular basis of developmental disorders and congenital anomalies associated with aberrant RUNX signaling.
Epigenetic and Transcriptional Regulation: Runx-IN-1 is also leveraged in research focused on epigenetic modulation and transcriptional control. By interfering with RUNX-mediated gene expression, scientists can dissect the crosstalk between transcription factors and chromatin remodeling complexes. This enables a deeper understanding of how epigenetic landscapes are shaped and maintained, providing a framework for exploring gene-environment interactions and the heritable transmission of gene expression patterns.
Signal Transduction Pathway Analysis: The inhibitor is a valuable resource for mapping signal transduction pathways that converge on RUNX transcription factors. Researchers apply Runx-IN-1 to assess the downstream effects of extracellular cues and intracellular signaling events on RUNX-driven gene expression. This application is particularly useful for identifying key nodes in signaling networks that integrate environmental stimuli with transcriptional responses, thereby advancing the field of systems biology and network pharmacology.
Runx-IN-1 continues to empower scientific discovery across multiple disciplines by offering a targeted approach to the study of transcriptional regulation. Its versatility and specificity make it a cornerstone reagent for researchers aiming to unravel the complexities of gene expression networks and their implications in health and disease.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More